Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Primary Effusion Lymphoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Lymphoma
Virus-Related Lymphoma
Primary Effusion Lymphoma

Hematologic Malignancy

Primary Effusion Lymphoma

CI-CAN-00003741PELExplore in graph →

Hematologic7 active trials

NCIt: C6915
OncoTree: PEL
UMLS CUI: C1292753
MeSH: D054685

Overview
Statistics
Survival
Genomics
Variants & evidence
Drugs
Trials14
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

14 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

StatusAll Active (any)Active Not Recruiting 5 Recruiting 3 Completed 2 Terminated 2 Not Yet Recruiting 1 Withdrawn 1

PhaseAll N/A 1 Phase 1 7 Phase 2 6

No study matches these filters